Model OGB21501 - Long-Acting Recombinant Protein

OGB21501 is a long-acting recombinant protein of GLP-1/GIP/GCG/FGF21 generated by applying our proprietory protein conjugation platform, UniStac, and it is a tetra-specific drug for the treatment of non-alcoholic steatohepatitis (NASH). It simultaneously targets four different mechanisms that are proven to be effective in resolving hepatic inflammation and fibrosis.